ReposiTrak (TRAK) director discloses board fee shares and stock sales

Rhea-AI Filing Summary

ReposiTrak, Inc. director reports stock grant and sales

A director of ReposiTrak, Inc. (TRAK) reported several transactions in the company’s common stock. On November 5, 2025, he acquired 1,265 shares, issued in lieu of cash compensation for his board service for the quarter ended September 30, 2025. On December 22, 2025, he sold 1,641 shares at a weighted average price of $13.1981, and on December 23, 2025 he sold an additional 18,906 shares at a weighted average price of $13.164. After these transactions, he beneficially owned 561,869 shares of ReposiTrak common stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HODGE RONALD C

(Last) (First) (Middle)

5282 S COMMERCE DRIVE, SUITE D-292

(Street)

MURRAY UT 84107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ReposiTrak, Inc. [ TRAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2025		A(1)		1,265	A	(1)	582,416	D
Common Stock	12/22/2025		S		1,641	D	$13.1981(2)	580,775	D
Common Stock	12/23/2025		S		18,906	D	$13.164(3)	561,869	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares issued in lieu of amounts payable to the Reporting Person for his service on the Issuer's Board of Directors for the quarter ended September 30, 2025.

2. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $13.15 to $13.1981, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

3. The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $13.00 to $13.164, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

	/s/ Ronald Hodge	12/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for ReposiTrak, Inc. (TRAK)?

The filing reports that a director of ReposiTrak, Inc. acquired 1,265 shares of common stock on November 5, 2025, and sold 1,641 shares on December 22, 2025 plus 18,906 shares on December 23, 2025.

At what prices did the ReposiTrak (TRAK) director sell shares?

The director’s December 22, 2025 sale of 1,641 shares was at a weighted average price of $13.1981, and the December 23, 2025 sale of 18,906 shares was at a weighted average price of $13.164.

Why did the ReposiTrak (TRAK) director receive 1,265 shares on November 5, 2025?

The 1,265 shares reported as acquired on November 5, 2025 were issued in lieu of amounts payable to the director for his service on the company’s Board of Directors for the quarter ended September 30, 2025.

How many ReposiTrak (TRAK) shares does the director own after these transactions?

Following the reported grant and sales, the director beneficially owned 561,869 shares of ReposiTrak common stock, held directly.

What is the reporting person’s relationship to ReposiTrak, Inc. (TRAK)?

The reporting person is identified as a director of ReposiTrak, Inc. and the form is filed by one reporting person.

Does the ReposiTrak (TRAK) filing mention how the sale prices were calculated?

Yes. For both sale dates, the filing states that the prices reported are weighted average prices, with the shares sold in multiple transactions within specified price ranges.